Strong evidence now supports the adoption of cervical cancer prevention strategies that
explicitly focus on persistent infection with the causal agent, human papillomavirus (HPV) …

This report investigates different options for using human papillomavirus (HPV) testing in
cervical cancer prevention. These options are evaluated by a stochastic model of the …

Cervical cancer is a major cause of death, and the second most frequent cancer in women
worldwide. Many studies have indicated a causal relation between genital human …

Use of human papillomavirus (HPV) testing in cervical cancer prevention is increasing
rapidly. A DNA test for 13 HPV types that can cause cervical cancer is approved in the …

Human Papillomavirus (HPV) vaccines will likely have an impact as a preventive strategy for
cervical cancer. Screening for precancerous lesions cannot be discontinued because …

Adding a test for human papillomavirus DNA to cervical-cancer screening КОРЗИНА ПОИСК
НАВИГАТОР ЖУРНАЛЫ КНИГИ ПАТЕНТЫ ПОИСК АВТОРЫ ОРГАНИЗАЦИИ КЛЮЧЕВЫЕ …

The validity of testing for high‐risk types of human papillomavirus (HPV) in cervical cancer
prevention programs is undetermined. We compared the performance on primary screening …

A wealth of evidence has led to the conclusion that virtually all cases of cervical cancer are
attributable to persistent infection by a subset of human papillomavirus (HPV) types …

Epidemiologic studies supported by molecular technology have provided sufficient evidence
of the causal role of some human papillomavirus (HPV) infections in the development of …

The discovery of the necessary cause of cervical cancer, human papillomavirus (HPV), has
led to important technological advances, including the development of molecular tests for …